Molecular fluorescence

Keywords:

Product News Download

[Good News] Nuoyuan Medical has been awarded the Sullivan GIL: Global Leader in R&D of Targeted Molecular Fluorescent Tracers.


From August 28 to 30, 2024, the 18th Sullivan China Growth, Innovation & Leadership Summit and the 3rd New Investment Conference were held in Shanghai. This year’s conference is themed “Unite New Forces, Achieve Quality-Driven Future,” aiming to bring together the wisdom and strength of global industry leaders, academics, research institutions, investors, and media to jointly explore new growth drivers, new markets, and new development paths for China’s economy in the new era.

The Party Secretary of China Pharmaceutical University Visits Nuoyuan Medical for Research and Investigation.


On the afternoon of December 14, Jin Nengming, Secretary of the Party Committee of China Pharmaceutical University, visited Nanjing Nuoyuan Medical Device Co., Ltd., a company founded by Cai Huiming, Chairman and alumnus of the Class of 1981. Accompanying him on the visit and exchange were several prominent alumni from the Class of 1981, including Tao Desheng, Vice Chairman of Lizhu Pharmaceutical Group; Sun Feng, Chairman of Shanghai Kangcheng Investment Management Co., Ltd.; and Zhang Yu, Chairman of Nanjing Yikang Pharmaceutical Co., Ltd., also an alumnus of the Class of 1981 based in Nanjing.